562 related articles for article (PubMed ID: 20877357)
21. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
22. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
23. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
McGranahan N; Swanton C
Cell; 2017 Feb; 168(4):613-628. PubMed ID: 28187284
[TBL] [Abstract][Full Text] [Related]
24. Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.
Foo J; Michor F
PLoS Comput Biol; 2009 Nov; 5(11):e1000557. PubMed ID: 19893626
[TBL] [Abstract][Full Text] [Related]
25. Tumour heterogeneity and resistance to cancer therapies.
Dagogo-Jack I; Shaw AT
Nat Rev Clin Oncol; 2018 Feb; 15(2):81-94. PubMed ID: 29115304
[TBL] [Abstract][Full Text] [Related]
26. Resolving genetic heterogeneity in cancer.
Turajlic S; Sottoriva A; Graham T; Swanton C
Nat Rev Genet; 2019 Jul; 20(7):404-416. PubMed ID: 30918367
[TBL] [Abstract][Full Text] [Related]
27. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
[TBL] [Abstract][Full Text] [Related]
28. Cancer heterogeneity: implications for targeted therapeutics.
Fisher R; Pusztai L; Swanton C
Br J Cancer; 2013 Feb; 108(3):479-85. PubMed ID: 23299535
[TBL] [Abstract][Full Text] [Related]
29. Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory.
Zhang L; Ma J; Liu L; Li G; Li H; Hao Y; Zhang X; Ma X; Chen Y; Wu J; Wang X; Yang S; Xu S
Crit Rev Oncol Hematol; 2023 Dec; 192():104192. PubMed ID: 37898477
[TBL] [Abstract][Full Text] [Related]
30. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
[TBL] [Abstract][Full Text] [Related]
31. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
32. Evolution of acquired resistance to anti-cancer therapy.
Foo J; Michor F
J Theor Biol; 2014 Aug; 355():10-20. PubMed ID: 24681298
[TBL] [Abstract][Full Text] [Related]
33. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.
Caswell DR; Swanton C
BMC Med; 2017 Jul; 15(1):133. PubMed ID: 28716075
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics.
Bradford R; Koppel H; Pilkington GJ; Thomas DG; Darling JL
J Neurooncol; 1997 Sep; 34(3):247-61. PubMed ID: 9258817
[TBL] [Abstract][Full Text] [Related]
35. Tumour heterogeneity and immune-modulation.
Jamal-Hanjani M; Thanopoulou E; Peggs KS; Quezada SA; Swanton C
Curr Opin Pharmacol; 2013 Aug; 13(4):497-503. PubMed ID: 23664091
[TBL] [Abstract][Full Text] [Related]
36. Implications of genetic heterogeneity in cancer.
Schmitt MW; Prindle MJ; Loeb LA
Ann N Y Acad Sci; 2012 Sep; 1267():110-6. PubMed ID: 22954224
[TBL] [Abstract][Full Text] [Related]
37. Rare Mutations in Cancer Drug Resistance and Implications for Therapy.
Beckman RA; Loeb LA
Clin Pharmacol Ther; 2020 Sep; 108(3):437-439. PubMed ID: 32648584
[No Abstract] [Full Text] [Related]
38. Breast cancer intratumor genetic heterogeneity: causes and implications.
Ng CK; Pemberton HN; Reis-Filho JS
Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222
[TBL] [Abstract][Full Text] [Related]
39. Fine-grained simulations of the microenvironment of vascularized tumours.
Fredrich T; Rieger H; Chignola R; Milotti E
Sci Rep; 2019 Aug; 9(1):11698. PubMed ID: 31406276
[TBL] [Abstract][Full Text] [Related]
40. Somatic clonal evolution: A selection-centric perspective.
Scott J; Marusyk A
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
